Emily Lough received her B.S. in Biomedical Engineering from Boston University in 2010. During her undergraduate career Emily worked with Dr. Simon Kasif in developing a computational model that predicts and quantifies a person’s response to various chemotherapeutic agents in the treatment of non-small cell lung cancer.
Emily entered the post-bachelor’s Ph.D. program in Biomedical Engineering in the fall of 2010. As a fellow in the NIH-funded Quantitative Biology and Physiology Training Program, Emily completed a research rotation in the Nanomedicine and Medical Acoustics Laboratory working on methods to reduce the surface charge of cationic gene carriers. In the spring of 2011, Emily officially joined the laboratory and is focusing on developing novel hybrid nano particles for targeted delivery of cisplatin for the treatment of ovarian cancer. Since joining the laboratory, Emily has participated in the Cross-Disciplinary Training in Nanotechnology for Cancer and has attended several drug delivery scientific meetings.